Hepatitis News : Large Study Highlights Threat of Hepatitis to Baby Boomers
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » November 2012


November 29, 2012

Large Study Highlights Threat of Hepatitis to Baby Boomers

Representing a major step forward in both assessing the health impact of viral hepatitis and acknowledging its significant threat to public health, a large study has underscored that the hepatitis B and C viruses disproportionately affect baby boomers, aidsmap reports. Published in the online edition of Clinical Infectious Diseases, the Chronic Hepatitis Cohort Study (CHeCS) reports that three quarters of hepatitis C virus (HCV) and half of hepatitis B virus (HBV) cases in the United States are among people born between 1945 and 1964.

The study examined electronic health records of the adult, chronically infected HCV and HBV populations between January 2006 and December 2010 in four health care systems in Detroit; Danville, Pennsylvania; Portland, Oregon; and Honolulu. Among the 2,202 hep B patients, 50 percent were between 44 and 63 years old. Among the 8,810 hep C patients, 75 percent were in the same age group. Between 2001 and 2010, 38.3 percent of the hep C patients had a liver biopsy and 44.3 percent were hospitalized. Among the HBV and HCV patients in care, 9 percent of those with hep B and 14 percent of those with hep C died between 2006 and 2010, most of them baby boomers. Researchers noted the “relative youth” of those who died, stressing the significant threat viral hepatitis poses to mortality.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: hepatitis C, hepatitis B, virus, viral hepatitis, HBV, HCV, Clinical Infectious Diseases, aidsmap, Chronic Hepatitis Cohort Study, CHeCS, baby boom, Detroit, Danville, Portland, Honolulu, health impact, mortality.

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Should Medicaid limit access to new hep C drugs?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.